Suppr超能文献

术后并发症对肝母细胞瘤患者总生存期的影响。

Impact of postoperative complications on overall survival of patients with hepatoblastoma.

作者信息

Becker Kristina, Furch Christiane, Schmid Irene, von Schweinitz Dietrich, Häberle Beate

机构信息

Department of Pediatric Surgery, Ludwig-Maximilian-University of Munich, Munich, Germany.

出版信息

Pediatr Blood Cancer. 2015 Jan;62(1):24-8. doi: 10.1002/pbc.25240. Epub 2014 Sep 22.

Abstract

BACKGROUND

Complete resection of hepatoblastoma (HB) is a demanding procedure in advanced tumors. Perioperative complications are still common. The influence of complication rates on course of disease and survival of patients with HB has not been analyzed yet.

PROCEDURES

Patients with high risk (HR) HB and standard-risk (SR) HB registered from 1999 to 2008 to the German prospective multicenter study HB99 were evaluated regarding perioperative complications, reasons (e.g., tumor size and vessel involvement) and impact on further treatment and overall survival (OS).

RESULTS

Surgical data from 126 patients were available (47 HR-HB, 79 SR-HB). Postoperative complications occurred in 26 (21%) patients consisting of biliary leakage (n = 9), cholestasis (n = 5), deficit of liver perfusion (n = 5) and others (n = 7). Twenty of these 26 patients (77%) required a second operation. The rate of postoperative complications was higher in the HR-group (26%) compared to the SR-group (17%). Patients with vessel involvement had significantly more complications (17% vs. 54%, P = 0.01). Patients with PRETEXT I/II-tumors had the same rate of postoperative complications (19% vs. 20%) as patients with PRETEXT III/IV. Patients of HR-group with postoperative complications showed delayed start in adjuvant chemotherapy (>21 d) (75% vs. 25%, n.s.) combined with significant lower 5-year-OS (75% vs. 50%, P = 0.02). In multivariate analysis postoperative complications were an independent negative prognostic factor for HR-patients (HR 3.1, P = 0.04).

CONCLUSIONS

Postoperative complications after HB resection are frequent and associated with worsened OS of patients with HR-HB. One possible reason is delay in postoperative chemotherapy. The approach to precarious liver resection should be carefully planned and executed by specialists.

摘要

背景

在晚期肝母细胞瘤(HB)中,完整切除肿瘤是一项具有挑战性的手术。围手术期并发症仍然很常见。并发症发生率对HB患者疾病进程和生存的影响尚未得到分析。

方法

对1999年至2008年登记参加德国前瞻性多中心研究HB99的高危(HR)HB和标准风险(SR)HB患者的围手术期并发症、原因(如肿瘤大小和血管受累情况)以及对进一步治疗和总生存(OS)的影响进行评估。

结果

获得了126例患者的手术数据(47例HR-HB,79例SR-HB)。26例(21%)患者发生术后并发症,包括胆漏(n = 9)、胆汁淤积(n = 5)、肝灌注不足(n = 5)和其他情况(n = 7)。这26例患者中有20例(77%)需要再次手术。HR组术后并发症发生率(26%)高于SR组(17%)。血管受累患者的并发症明显更多(17%对54%,P = 0.01)。PRETEXT I/II期肿瘤患者与PRETEXT III/IV期患者的术后并发症发生率相同(19%对20%)。HR组有术后并发症的患者辅助化疗开始延迟(>21天)(75%对25%,无统计学差异),且5年总生存率显著降低(75%对50%,P = 0.02)。多因素分析显示,术后并发症是HR患者独立的不良预后因素(HR 3.1,P = 0.04)。

结论

HB切除术后的并发症很常见,且与HR-HB患者的总生存率降低有关。一个可能的原因是术后化疗延迟。复杂肝切除术的手术方案应由专家仔细规划并实施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验